Early antidepressant exposure rewrites the script of coping.

Area of Science:

• Environmental toxicology
• Neuroscience
• Ecotoxicology

Background:

• Neuropharmaceuticals, including antidepressants like paroxetine (PAR), are increasingly found in aquatic environments.
• Early-life exposure to these compounds can impact brain development and lead to long-lasting behavioral changes.
• Understanding these effects is crucial for assessing ecological risks and population adaptability.

Purpose of the Study:

• To investigate the effects of early developmental exposure to environmental levels of paroxetine (PAR) on zebrafish stress-coping behaviors.
• To determine if transient embryonic exposure to PAR causes lasting alterations in behavior and neuroendocrine function.

Main Methods:

• Zebrafish embryos were exposed to environmentally relevant concentrations of PAR (0.04 and 0.4 µg/L) during a critical developmental window (3-48 hours post-fertilization).
• Following exposure, larvae and juveniles were assessed for behavioral changes at 8 and 45 days post-fertilization, respectively.
• Neurotransmitter systems and endocrine regulation were analyzed at the juvenile stage.

Main Results:

• Transient embryonic exposure to PAR disrupted the development of normal coping styles in zebrafish.
• Early behavioral alterations persisted and progressed into more pronounced, phenotype-specific disruptions by the juvenile stage.
• PAR exposure led to significant changes in monoaminergic and endocrine regulations.

Conclusions:

• Developmental exposure to environmental concentrations of paroxetine can have profound and lasting effects on fish behavior and neurobiology.
• These disruptions in stress-coping mechanisms may have significant ecological implications for fish populations adapting to anthropogenic pressures.
• The study highlights the need for monitoring and managing pharmaceutical pollution in aquatic ecosystems.